AP: Generic drug competition amendment approved as part of Food and Drug Act

WASHINGTON — An amendment to improve generic drug competition has been approved as part of the Food and Drug Reauthorization Act, U.S. Sen. Susan Collins (R-Maine) told The Associated Press.

Collins said the amendment was approved May 11 at a Senate Health, Education, Labor and Pensions Committee business meeting, adding the measure is part of an investigation into "aggressive price hikes" in prescription drugs, and it will improve generic drug competition to help make prices lower.

It's identical to legislation introduced by Collins and Sen. Claire McCaskill (D-Miss.), AP reported.

To read more, click here.